Evidence map›Paper›PMID 31076628›Full record

ArticleScientific reports2019

σ

Rémi Hocq, Maxime Bouilloux-Lafont, Nicolas Lopes Ferreira, François Wasels

Abstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Anaerobic benzene oxidation inApplied and environmental microbiology · 2024
    Article
  2. Role of two RpoN inFrontiers in microbiology · 2023
    Article
  3. Article
  4. Sporulation in solventogenic and acetogenic clostridia.Applied microbiology and biotechnology · 2021
    Review
  5. Article
  6. Article
  7. Phenotypic and Genomic Analysis ofFrontiers in bioengineering and biotechnology · 2020
    Article
  8. Review
  9. Genomic reconstruction of σBMC genomics · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Rémi HocqIFP Energies nouvelles, 1 et 4 avenue de Bois-Préau, 92852, Rueil-Malmaison, France.
Maxime Bouilloux-LafontIFP Energies nouvelles, 1 et 4 avenue de Bois-Préau, 92852, Rueil-Malmaison, France.
Nicolas Lopes FerreiraIFP Energies nouvelles, 1 et 4 avenue de Bois-Préau, 92852, Rueil-Malmaison, France.
François WaselsIFP Energies nouvelles, 1 et 4 avenue de Bois-Préau, 92852, Rueil-Malmaison, France. francois.wasels@ifpen.fr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The solventogenic C. beijerinckii DSM 6423, a microorganism that naturally produces isopropanol and butanol, was previously modified by random mutagenesis. In this work, one of the resulting mutants was characterized. This strain, selected with allyl alcohol and designated as the AA mutant, shows a dominant production of acids, a severely diminished butanol synthesis capacity, and produces acetone instead of isopropanol. Interestingly, this solvent-deficient strain was also found to have a limited consumption of two carbohydrates and to be still able to form spores, highlighting its particular phenotype. Sequencing of the AA mutant revealed point mutations in several genes including CIBE_0767 (sigL), which encodes the σ

Indexed as

2-PropanolBacterial ProteinsButanolsCarbonClostridium beijerinckiiCRISPR-Cas SystemsEthanolGene EditingGlucosePhenotypePoint MutationSigma FactorSolvents2-PropanolBacterial ProteinsButanolsCarbonEthanolGlucoseSigma FactorSolvents

Identifiers

PMID31076628
PMCPMC6510779

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.